Try our Advanced Search for more refined results
FIAC Corp., et al
Case Number:
1:16-bk-12238
Court:
Nature of Suit:
Firms
- Archer & Greiner
- Ashby & Geddes
- Brown Rudnick
- Chipman Brown
- DLA Piper
- Gellert Scali
- Holland & Knight
- Hopkins & Carley
- King & Spalding
- Kutak Rock
- Landis Rath
- Olshan Frome
- Pachulski Stang
- Reed Smith
- Richards Layton
- Saul Ewing
- Sheppard Mullin
- Simpson Thacher
- Stevens & Lee
- Willkie Farr
- Young Conaway
Companies
- FTI Consulting Inc.
- Hain Capital Group LLC
- Kurtzman Carson Consultants LLC
- L3Harris Technologies Inc.
- Leidos Holdings Inc.
- Marcum LLP
- Noble Capital Markets Inc.
- Platinum Partners LP
- TR Capital Management LLC
- Wells Fargo & Co.
- Western Alliance Bancorporation
Sectors & Industries:
-
August 03, 2017
Implant Sciences Ch. 11 Confirmed, Cash Fight Continues
Warnings of battles to come clouded a Delaware Chapter 11 confirmation on Thursday for remnants of former bomb detection company Implant Sciences, with an equity committee attorney objecting to what he said were eleventh-hour moves to drain extra cash from the estate.
-
June 23, 2017
Judge Denies Implant Sciences Investors A Solicitation Agent
A request from shareholders of bomb detection hardware maker Implant Sciences to retain a solicitation agent for the company's proposed Chapter 11 plan failed to receive court approval Friday in Delaware because the court determined the services were unnecessary.
-
June 22, 2017
Implant Sciences, Watchdog Protest Bid For Consultant
Both the Implant Sciences bankruptcy estate and the U.S. Trustee's Office balked Thursday at the official equity committee's bid to hire a consultant as its own solicitation agent for the bomb detection firm's Chapter 11 plan, a measure the debtor and watchdog argue is unreasonable.
-
June 14, 2017
Implant Sciences Gets Tentative OK On Ch. 11 Disclosures
A Delaware bankruptcy judge agreed Wednesday to OK the disclosure statement for the former Implant Sciences' Chapter 11 plan, but left the door open for additional rulings, including on competing add-ons to the document from the bomb detector maker and its shareholders that turned into a dispute that morning.
-
June 05, 2017
Implant Sciences Equity Holder, Lender Settlement Wins OK
Shareholders of bomb detector maker Implant Sciences received court approval Monday in Delaware for a $55 million settlement fund that resolves the claims of a group of prepetition lenders asserting claims of more than $63 million in the bankruptcy case.
-
April 04, 2017
Implant Sciences Investors Denied Expanded Standing
A Delaware bankruptcy judge Monday denied a bid by a stockholders committee to expand its limited standing to sue bankrupt Implant Sciences Corp.'s lenders, saying the standing issue had "played itself out."
-
March 23, 2017
Judge Wary Of More Leeway To Sue Implant Sciences Lenders
A bid by a stockholders committee to expand its limited standing to sue bankrupt Implant Sciences Corp.'s lenders could send ripples well beyond the already-sold explosive detector maker's case, a Delaware bankruptcy judge said Thursday.
-
January 30, 2017
Implant Sciences Investors Can Sue In NY Amid Ch. 11
Investors in bankrupt and already-sold Implant Sciences Corp. got a conditional go-ahead Monday to sue the company's pre-Chapter 11 lenders in a New York state court, under a trimmed set of claims that a Delaware bankruptcy judge said should first go to mediation.
-
January 27, 2017
IMX Equity Panel Denies Ch. 11 Sabotage Claim By Lenders
The IMX Acquisition Corp. equity committee's attorneys denied accusations Friday that their proposed suit against key prebankruptcy lenders is an attempt to sabotage IMX's Chapter 11, and urged a judge to allow their case to head for a New York state courtroom.
-
January 25, 2017
Implant Sciences Equity Holders Say Adviser Is Conflicted
The committee of equity holders of bankrupt bomb detection device maker Implant Sciences objected in Delaware on Wednesday to the fee application of the company's investment banker, saying the adviser failed to disclose a prior business relationship between the adviser, the company and its secured lenders.